Skip to main content
. 2020 Jan 6;9(1):154. doi: 10.3390/jcm9010154

Table 4.

Adverse events (any grade) experienced during the treatment.

Adverse Events (n = 52) Number of Adverse Effects (%) Prevalence of Adverse Effects in the Study Population (n = 83) (%)
Weight gain 21 (30.1) 25.3
Abnormal uterine bleeding * 14 (26.9) 16.9
Headache 11 (21.2) 13.3
Depression 5 (9.6) 6.0
Decrease libido 2 (3.8) 2.4
Acne 1 (1.9) 1.2

* Consisting in irregular bleeding cycle or intermenstrual spotting/bleeding.